期刊文献+

Advances on hypoxia inducible factor-1 被引量:9

Advances on hypoxia inducible factor-1
原文传递
导出
摘要 Hypoxia inducible factor-1 (HIF-1) was first discovered by Semenza et al1 in 1991 as a protein which couldspecifically bind to the oligonucleotide sequence of the erythropoietin gene enhancer. The dimmers of HIF-1 were isolated in the following year. As its subunits were found to be induced by hypoxic conditions, it was subsequently named as hypoxia inducible factor.2 HIF-1, commonly found in human and mammalian cells, also expressed in normoxic conditions. However, under physiological conditions, the intracellular HIF-1 protein soon degrades through the oxygen-dependent ubiquitin protease degradation pathway, but is stable under hypoxic conditions.3 HIF-1 is a transcription factor responding to hypoxia and includes a wide range of target gene spectrum. The expressed proteins can produce a series of reactions, including cell oxygen balance, energy metabolism, apoptosis, immune responses, cytokine production, angiogenesis, tumor invasion, and radiotherapy resistance, etc.4'5 In recent years, more and more research has proposed that HIF-1 is a critical transcription factor in the maintenance of oxygen homeostasis and regulation of the hypoxia responses, and that HIF is the most important approach by which the hypoxia inducible gene transcription information transmitted. Hypoxia inducible factor-1 (HIF-1) was first discovered by Semenza et al1 in 1991 as a protein which couldspecifically bind to the oligonucleotide sequence of the erythropoietin gene enhancer. The dimmers of HIF-1 were isolated in the following year. As its subunits were found to be induced by hypoxic conditions, it was subsequently named as hypoxia inducible factor.2 HIF-1, commonly found in human and mammalian cells, also expressed in normoxic conditions. However, under physiological conditions, the intracellular HIF-1 protein soon degrades through the oxygen-dependent ubiquitin protease degradation pathway, but is stable under hypoxic conditions.3 HIF-1 is a transcription factor responding to hypoxia and includes a wide range of target gene spectrum. The expressed proteins can produce a series of reactions, including cell oxygen balance, energy metabolism, apoptosis, immune responses, cytokine production, angiogenesis, tumor invasion, and radiotherapy resistance, etc.4'5 In recent years, more and more research has proposed that HIF-1 is a critical transcription factor in the maintenance of oxygen homeostasis and regulation of the hypoxia responses, and that HIF is the most important approach by which the hypoxia inducible gene transcription information transmitted.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第18期3567-3571,共5页 中华医学杂志(英文版)
关键词 hypoxia inducible factor-1 HYPOXIA biological characteristic ANGIOGENESIS TUMOR hypoxia inducible factor-1 hypoxia biological characteristic angiogenesis tumor
  • 相关文献

参考文献1

二级参考文献9

  • 1任瑞美,于金明,孙新东,张建东,宋现让,柳永蕾,尹勇.RNA干扰HIF-1α增强人肺腺癌SPCA-1细胞放射敏感性的研究[J].中华放射肿瘤学杂志,2005,14(6):503-506. 被引量:8
  • 2Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation[J]. Mol Cell Biol, 1992, 12(12): 5447--5454.
  • 3Brahimi-Horn C, Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion[J]. Bull Cancer, 2006, 93(8): E73-E80.
  • 4Vaupel P. The role of hypoxia-induced factors in tumor progression[J]. Oncologist, 2004, 9 Suppl 5: 10--17.
  • 5Song X, Liu X, Chi W, et al. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF--lalpha gene[J]. Cancer Chemother Pharmacol. 2006, 58(6): 776-784.
  • 6Weinmann M, Belka C, Plasswilm L. Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours [J]. Onkologie, 2004, 27(1): 83-90.
  • 7Melillo G. Inhibiting hypoxia-inducible factor 1 for cancer therapy[J]. Mol Cancer Res, 2006, 4(9): 601-605.
  • 8Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression[J]. Nature, 2006, 441 (7092): 437-443.
  • 9Moeller BJ, Dreher MR, Rabbani ZN, et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity[J]. Cancer Cell, 2005, 8 (2): 99-110.

共引文献9

同被引文献54

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部